Preclinical Development

XOMA has fully integrated IND-enabling capabilities, led by experts in the field of pharmacology, pharmacokinetics and toxicology. Working together with the antibody discovery group and the clinical group, our pharmacology group designs and conducts studies needed to assist clinical rationale and translational medicine programs.

The pharmacokinetics and pharmacodynamics group has renowned expertise in modeling of preclinical and clinical data as well as population analysis of data. The toxicology group is responsible for the safety evaluation of our drug candidates. The cohesive nature of our preclinical development team and its dedication ensure that we provide high quality and scientifically relevant IND-enabling studies to support safety and clinical development.